Ojha Ashutosh, Ojha Utkarsh, Ojha Harsh, Chandrashekar Abhinaya, Mohammed Raihan, Trivedi Rudra, Ugaonkar Sharvari, Desai Manan, Sreevidya Ramesh, Sahu Pratiksha
Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's Narsee Monjee Institute of Management Studies, Mumbai, India.
Faculty of Medicine, Imperial College London, London, UK.
Int J Gen Med. 2020 Jan 13;13:1-8. doi: 10.2147/IJGM.S220444. eCollection 2020.
To understand doctors' attitude to and awareness of AYUSH therapies for the treatment of diabetes mellitus (DM).
This qualitative study, using a usage-and-attitude survey, was conducted in secondary centers across Mumbai, India. The study surveyed 77 physicians, including those specializing in diabetes.
The majority of doctors were aware of Ayurveda (69%) and Homeopathy (52%). Some doctors were aware of Unani (34%) and Siddha (32%). Most doctors (60%) thought that Ayurveda was effective in some way. Almost all doctors (97%) thought that allopathic medicine was effective for DM. The majority of doctors (68%) had not recommended AYUSH therapies as an adjunct to modern medicines. Approximately half of the doctors (52%) believed that AYUSH therapies posed a safety concern for patients and 46% thought that AYUSH therapies could not be used to manage any form of DM. A large group of doctors thought that the main barrier preventing AYUSH therapies from being integrated into current allopathic management of DM was the lack of strong scientific evidence and clinical trials.
The majority of doctors are aware to some degree of Ayurveda and homeopathic forms of treatment. The majority believe that AYUSH therapies pose a safety concern for patients and have no role in treatment for any form of DM. The most common barrier preventing AYUSH therapies from becoming a mainstream treatment option for DM is the lack of scientific evidence. From this sample, it seems that greater efforts are required to conduct research into the efficacy and safety of AYUSH therapies to ensure that doctors are able to provide holistic care for patients with DM.
了解医生对阿育吠陀医学、尤那尼医学、悉达医学和顺势疗法（AYUSH）治疗糖尿病（DM）的态度和认知。
本定性研究采用使用与态度调查方法，在印度孟买的二级医疗中心开展。该研究调查了77名医生，包括糖尿病专科医生。
大多数医生知晓阿育吠陀医学（69%）和顺势疗法（52%）。一些医生知晓尤那尼医学（34%）和悉达医学（32%）。大多数医生（60%）认为阿育吠陀医学在某种程度上有效。几乎所有医生（97%）认为对抗疗法药物对糖尿病有效。大多数医生（68%）未推荐将AYUSH疗法作为现代药物的辅助疗法。约一半医生（52%）认为AYUSH疗法对患者存在安全问题，46%的医生认为AYUSH疗法无法用于治疗任何形式的糖尿病。一大群医生认为，阻碍AYUSH疗法融入当前糖尿病对抗疗法管理的主要障碍是缺乏有力的科学证据和临床试验。
大多数医生在一定程度上知晓阿育吠陀医学和顺势疗法。大多数人认为AYUSH疗法对患者存在安全问题，在任何形式糖尿病的治疗中都不起作用。阻碍AYUSH疗法成为糖尿病主流治疗选择的最常见障碍是缺乏科学证据。从这个样本来看，似乎需要加大力度对AYUSH疗法的疗效和安全性进行研究，以确保医生能够为糖尿病患者提供全面护理。
